An evaluation of abrocitinib for moderate-to-severe atopic dermatitis
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Clinical Immunology"
DOI: 10.1080/1744666x.2022.2126353
Abstract: ABSTRACT Introduction Atopic dermatitis (AD) is a common itchy inflammatory skin condition that affects many individuals. For many years, the landscape of AD treatment remained unchanged; however, there has been developing therapies that directly target… read more here.
Keywords: atopic dermatitis; evaluation abrocitinib; moderate severe; abrocitinib ... See more keywords